SYRS - Syros Pharmaceuticals (SYRS) CEO Nancy Simonian on Q2 2019 Results - Earnings Call Transcript
Syros Pharmaceuticals (SYRS)
Q2 2019 Earnings Conference Call
August 1, 2019 08:30 ET
Company Participants
Naomi Aoki - Investor Relations
Nancy Simonian - Chief Executive Officer
Joe Ferra - Chief Financial Officer
David Roth - Chief Medical Officer
Eric Olson - Chief Scientific Officer
Jeremy Springhorn - Chief Business Officer
Conference Call Participants
Phil Nadeau - Cowen & Company
Ted Tenthoff - Piper Jaffray
Jason Butler - JMP Securities
Matt Biegler - Oppenheimer
Zegbeh Jallah - ROTH Capital Partners
Presentation
Naomi Aoki
Thank you. This morning, we issued a press release with our second quarter